Skip to main content
PMC home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1996 Apr 1;154(7):1041–1047.

Recent trends in pediatric Haemophilus influenzae type B infections in Canada. Immunization Monitoring Program, Active (IMPACT) of the Canadian Paediatric Society and the Laboratory Centre for Disease Control.

D W Scheifele 1
PMCID: PMC1487572  PMID: 8625025

Abstract

OBJECTIVE: To describe changes in the number of cases of Haemophilus influenzae type b (Hib) infections among Canadian children before and after the introductory phases of Hib vaccination. DESIGN: Multicentre case series. SETTING: All 10 pediatric tertiary care centres across Canada participating in the Immunization Monitoring Program, Active (IMPACT) of the Canadian Paediatric Society and the Laboratory Centre for Disease control. PATIENTS: Children with a Hib infection admitted to any of the participating hospitals from 1985 to 1994. Annual case totals from 1985 to 1990 were determined from records of hospital laboratories or coded discharge diagnoses, or both. From 1991 to 1994 intensive case surveillance was conducted on the wards in addition to thorough record searches as above. OUTCOME MEASURES: Estimated annual case totals for 1985-90. For 1991-94 intensive surveillance for quarterly case totals, yearly age distribution of cases, and proportion of recent cases that represent vaccination failures or missed opportunities to prevent infection. RESULTS: The total number of Hib cases from 1985 to 1990 was 2095; from 1991 to 1994, there were 326 laboratory-confirmed cases and 15 probably cases supported by Hib antigen detection. The annual number of cases declined from an estimated 485 in 1985 to 24 in 1994, a decrease of 95.1%. The steepest interannual decrease (63.7%) occurred between 1992 and 1993, following the introduction of infant-based vaccination programs across Canada. The number of Hib cases involving children most at risk (those 6 to 18 months old) decreased from 78 in 1991 to 4 in 1994. Of the 24 cases in 1994, 6 were categorized as preventable, 1 was fatal, and 8 were vaccine failures (2 of which involved currently used vaccines). CONCLUSION: The prevalence of Hib infections reported by the IMPACT centres has declined greatly since the introduction of vaccination programs. However, deaths and complications continue to occur, attesting to the need to vaccinate all eligible infants and children against this virulent pathogen.

Full text

PDF
1041

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams W. G., Deaver K. A., Cochi S. L., Plikaytis B. D., Zell E. R., Broome C. V., Wenger J. D. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA. 1993 Jan 13;269(2):221–226. [PubMed] [Google Scholar]
  2. Barbour M. L., Mayon-White R. T., Coles C., Crook D. W., Moxon E. R. The impact of conjugate vaccine on carriage of Haemophilus influenzae type b. J Infect Dis. 1995 Jan;171(1):93–98. doi: 10.1093/infdis/171.1.93. [DOI] [PubMed] [Google Scholar]
  3. Broome C. V. Epidemiology of Haemophilus influenzae type b infections in the United States. Pediatr Infect Dis J. 1987 Aug;6(8):779–782. doi: 10.1097/00006454-198708000-00036. [DOI] [PubMed] [Google Scholar]
  4. Hay J. W., Daum R. S. Cost-benefit analysis of Haemophilus influenzae type b prevention: conjugate vaccination at eighteen months of age. Pediatr Infect Dis J. 1990 Apr;9(4):246–252. doi: 10.1097/00006454-199004000-00005. [DOI] [PubMed] [Google Scholar]
  5. Jadavji T., Biggar W. D., Gold R., Prober C. G. Sequelae of acute bacterial meningitis in children treated for seven days. Pediatrics. 1986 Jul;78(1):21–25. [PubMed] [Google Scholar]
  6. Janai H., Stutman H. R., Marks M. I. Invasive Haemophilus influenzae type B infections: a continuing challenge. Am J Infect Control. 1990 Jun;18(3):160–166. doi: 10.1016/0196-6553(90)90181-q. [DOI] [PubMed] [Google Scholar]
  7. Klein J. O., Feigin R. D., McCracken G. H., Jr Report of the Task Force on Diagnosis and Management of Meningitis. Pediatrics. 1986 Nov;78(5 Pt 2):959–982. [PubMed] [Google Scholar]
  8. Murphy T. V., White K. E., Pastor P., Gabriel L., Medley F., Granoff D. M., Osterholm M. T. Declining incidence of Haemophilus influenzae type b disease since introduction of vaccination. JAMA. 1993 Jan 13;269(2):246–248. [PubMed] [Google Scholar]
  9. Scheifele D., Bjornsen G. L., Arcand T., Jacobsen K. Antigenuria after receipt of Haemophilus b diphtheria toxoid conjugate vaccine. Pediatr Infect Dis J. 1989 Dec;8(12):887–888. doi: 10.1097/00006454-198912000-00014. [DOI] [PubMed] [Google Scholar]
  10. Schoendorf K. C., Adams W. G., Kiely J. L., Wenger J. D. National trends in Haemophilus influenzae meningitis mortality and hospitalization among children, 1980 through 1991. Pediatrics. 1994 Apr;93(4):663–668. [PubMed] [Google Scholar]
  11. Sherry B., Emanuel I., Kronmal R. A., Smith A. L., Char L. F., Gale J. L., Walkley E. Interannual variation of the incidence of Haemophilus influenzae type b meningitis. JAMA. 1989 Apr 7;261(13):1924–1929. [PubMed] [Google Scholar]
  12. Standaert S. M., Lefkowitz L. B., Jr, Horan J. M., Hutcheson R. H., Schaffner W. The reporting of communicable diseases: a controlled study of Neisseria meningitidis and Haemophilus influenzae infections. Clin Infect Dis. 1995 Jan;20(1):30–36. doi: 10.1093/clinids/20.1.30. [DOI] [PubMed] [Google Scholar]
  13. Vadheim C. M., Greenberg D. P., Eriksen E., Hemenway L., Christenson P., Ward B., Mascola L., Ward J. I. Protection provided by Haemophilus influenzae type b conjugate vaccines in Los Angeles County: a case-control study. Pediatr Infect Dis J. 1994 Apr;13(4):274–280. doi: 10.1097/00006454-199404000-00006. [DOI] [PubMed] [Google Scholar]
  14. Wenger J. D., Pierce R., Deaver K. A., Plikaytis B. D., Facklam R. R., Broome C. V. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in US children aged 18-59 months. Haemophilus Influenzae Vaccine Efficacy Study Group. Lancet. 1991 Aug 17;338(8764):395–398. [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES